Xeris Biopharma Holdings, Inc. (0A8E.L) LSE

7.25

-0.0289(-0.40%)

Updated at December 24 02:46PM

Currency In USD

Valuation

Market Cap497.56M
Enterprise Value697.39M
P/E Ratio-35.14
PEG Ratio-1.32
Price/Sales Ratio4.86
Price/Book Ratio-58.26
Enterprise/Revenue5.67
Enterprise/EBITDA188.59

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.13
Operating Margin-0.04

Management Effectiveness

Return On Assets-0.1
Return On Equity1.14

Income Statement

Revenue203.07M
Revenue/Share1.58
Gross Profit166.24M
EBITDA-13.99M
Net Income-54.84M
Diluted EPS-0.37

Balance Sheet

Total Cash91.6M
Total Cash/Share0.38
Total Debt38.19M
Total Debt/Equity-13.32
Current Ratio1.95
Book Value Per Share-0.12

Price History

52-Week Change114.56
52-Week High7.25
52-Week Low1.28
Moving Average 50 Days2.68
Moving Average 200 Days2.36

Statistics

Average Volume8,763
Shares Outstanding165.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A